Search research articles
Contact Us
Filters
Showing results (521-530 of 560) with videos related to
Page
of 56
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 14, 2003
Progress in the management of gynecologic cancer: consensus summary statement
Stephen A Cannistra, Robert C Bast, Jonathan S Berek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 27, 2004
Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis
Karen H Lu, Andrea P Patterson, Lin Wang, et al.
Cancer
|
November 13, 2019
Poly(adenosine diphosphate ribose) polymerase inhibitors induce autophagy-mediated drug resistance in ovarian cancer cells, xenografts, and patient-derived xenograft models
Janice M Santiago-O'Farrill, S John Weroha, Xiaonan Hou, et al.
Bone Marrow Transplantation
|
June 13, 2000
High-dose ifosfamide and etoposide with filgrastim for stem cell mobilization in patients with advanced ovarian cancer
M L Donato, D Gershenson, C Ippoliti, et al.
Chemical Science
|
June 24, 2021
Directed evolution of cyclic peptides for inhibition of autophagy
Joshua P Gray, Md Nasir Uddin, Rajan Chaudhari, et al.
Cancer Research
|
August 2, 2001
Genetic analysis of early- versus late-stage ovarian tumors
V Shridhar, J Lee, A Pandita, et al.
Iscience
|
November 17, 2025
DIRAS3-derived cyclic peptides disrupt KRAS-RAF interaction and KRAS nanoclustering, suppressing KRAS-driven pancreatic and ovarian tumors
Joshua P Gray, Gamze Bildik, Ha-Neul Kim, et al.
Cancers
|
February 26, 2020
Proteome Profiling Uncovers an Autoimmune Response Signature That Reflects Ovarian Cancer Pathogenesis
Makoto Kobayashi, Hiroyuki Katayama, Ehsan Irajizad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2003
Role of decreased levels of lipid phosphate phosphatase-1 in accumulation of lysophosphatidic acid in ovarian cancer
Janos L Tanyi, Yutaka Hasegawa, Ruth Lapushin, et al.
The Journal of Clinical Investigation
|
June 1, 2022
SIK2 inhibition enhances PARP inhibitor activity synergistically in ovarian and triple-negative breast cancers
Zhen Lu, Weiqun Mao, Hailing Yang, et al.
Page
of 56
Search research articles
Search
Showing results (521-530 of 560) with videos related to
Sort By:
Page
of 56
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 14, 2003
Progress in the management of gynecologic cancer: consensus summary statement
Stephen A Cannistra, Robert C Bast, Jonathan S Berek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 27, 2004
Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis
Karen H Lu, Andrea P Patterson, Lin Wang, et al.
Cancer
|
November 13, 2019
Poly(adenosine diphosphate ribose) polymerase inhibitors induce autophagy-mediated drug resistance in ovarian cancer cells, xenografts, and patient-derived xenograft models
Janice M Santiago-O'Farrill, S John Weroha, Xiaonan Hou, et al.
Bone Marrow Transplantation
|
June 13, 2000
High-dose ifosfamide and etoposide with filgrastim for stem cell mobilization in patients with advanced ovarian cancer
M L Donato, D Gershenson, C Ippoliti, et al.
Chemical Science
|
June 24, 2021
Directed evolution of cyclic peptides for inhibition of autophagy
Joshua P Gray, Md Nasir Uddin, Rajan Chaudhari, et al.
Cancer Research
|
August 2, 2001
Genetic analysis of early- versus late-stage ovarian tumors
V Shridhar, J Lee, A Pandita, et al.
Iscience
|
November 17, 2025
DIRAS3-derived cyclic peptides disrupt KRAS-RAF interaction and KRAS nanoclustering, suppressing KRAS-driven pancreatic and ovarian tumors
Joshua P Gray, Gamze Bildik, Ha-Neul Kim, et al.
Cancers
|
February 26, 2020
Proteome Profiling Uncovers an Autoimmune Response Signature That Reflects Ovarian Cancer Pathogenesis
Makoto Kobayashi, Hiroyuki Katayama, Ehsan Irajizad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2003
Role of decreased levels of lipid phosphate phosphatase-1 in accumulation of lysophosphatidic acid in ovarian cancer
Janos L Tanyi, Yutaka Hasegawa, Ruth Lapushin, et al.
The Journal of Clinical Investigation
|
June 1, 2022
SIK2 inhibition enhances PARP inhibitor activity synergistically in ovarian and triple-negative breast cancers
Zhen Lu, Weiqun Mao, Hailing Yang, et al.
Page
of 56